Clinical Trial: Safety, Tolerability and PK of ATTO-3712 in Healthy Volunteers and Patients With Atopic Dermatitis

U.S., Oct. 4 -- ClinicalTrials.gov registry received information related to the study (NCT07205081) titled 'Safety, Tolerability and PK of ATTO-3712 in Healthy Volunteers and Patients With Atopic Dermatitis' on Sept. 24.

Brief Summary: The goal of this clinical trial is to assess the safety, tolerability, and pharmacokinetics of ATTO-3712 in healthy adults and patients with atopic dermatitis.

The main questions it aims to answer are:

What medical problems do participants have when taking ATTO-3712? How long does ATTO-3712 stay in the body after dosing? Researchers will compare ATTO-3712 to a placebo (a look-alike substance that contains no drug).

Participants will be dosed with ATTO-3712 or a placebo, visit the clinic for checkups and t...